Your browser doesn't support javascript.
loading
Macular thickness fluctuation in neovascular age-related macular degeneration treated with anti-vascular endothelial growth factor.
Chen, Eric R; Chen, Andrew X; Greenlee, Tyler E; Conti, Thais F; Briskin, Isaac N; Urbano, Catherine A; Kalur, Aneesha; Kaiser, Peter K; Singh, Rishi P.
Afiliación
  • Chen ER; Case Western Reserve University School of Medicine, Cleveland, Ohio.
  • Chen AX; Case Western Reserve University School of Medicine, Cleveland, Ohio;; Center for Ophthalmic Bioinformatics, Cole Eye Institute, Cleveland Clinic, Cleveland, Ohio.
  • Greenlee TE; Center for Ophthalmic Bioinformatics, Cole Eye Institute, Cleveland Clinic, Cleveland, Ohio.
  • Conti TF; Center for Ophthalmic Bioinformatics, Cole Eye Institute, Cleveland Clinic, Cleveland, Ohio.
  • Briskin IN; Department of Quantitative Health Sciences, Cleveland Clinic, Cleveland, Ohio.
  • Urbano CA; Case Western Reserve University School of Medicine, Cleveland, Ohio.
  • Kalur A; Center for Ophthalmic Bioinformatics, Cole Eye Institute, Cleveland Clinic, Cleveland, Ohio.
  • Kaiser PK; Case Western Reserve University School of Medicine, Cleveland, Ohio;; Center for Ophthalmic Bioinformatics, Cole Eye Institute, Cleveland Clinic, Cleveland, Ohio.
  • Singh RP; Case Western Reserve University School of Medicine, Cleveland, Ohio;; Center for Ophthalmic Bioinformatics, Cole Eye Institute, Cleveland Clinic, Cleveland, Ohio;. Electronic address: drrishisingh@gmail.com.
Can J Ophthalmol ; 57(5): 350-356, 2022 10.
Article en En | MEDLINE | ID: mdl-34283969
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Ranibizumab / Degeneración Macular Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Can J Ophthalmol Año: 2022 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Ranibizumab / Degeneración Macular Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Can J Ophthalmol Año: 2022 Tipo del documento: Article